Ernexa Therapeutics Inc.
ERNANASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.57M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.92$23.00
- Volume (live)
- -
- Avg. volume (3M)
- 48.40K
Ernexa Therapeutics (ERNA) Stock Price & Financial Analysis
Ernexa Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.04 - $2.23 |
|---|---|
| 52-Week High | $23.00 |
| 52-Week Low | $0.92 |
| Open | $2.17 |
| Volume (last close) | 24.08K |
| Average Volume (3M) | 48.40K |
| 50-Day MA | $3.85 |
|---|---|
| 200-Day MA | $5.45 |
| 1-Year Change | +77.87% |
| Market Cap | 2.57M |
|---|---|
| Shares Outstanding | 1.18M |
| Price to Book (P/B) | 0.80 |
| EV/EBITDA | 0.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Ernexa Therapeutics at a Glance
As of the Oct 16, 2026 close, Ernexa Therapeutics (ERNA) has a market capitalization of $2.57M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $5.03M in cash and securities against $349.00K of debt, a net cash position of $4.68M.
Ernexa Therapeutics does not currently pay a dividend.
The share price is up 77.9% over the past year. At $2.09 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.92 to $23.00, below its 200-day moving average of $5.45.
Frequently Asked Questions About Ernexa Therapeutics
What is the current stock price for ERNA?
As of the Oct 16, 2026 close, ERNA stock trades at $2.09. The 52-week range is $0.92–$23.00, with a day range of $2.04–$2.23.
What is the P/E ratio for ERNA?
The P/E ratio (Price-to-Earnings) for ERNA is shown in the Key Statistics section. This valuation metric helps compare Ernexa Therapeutics Inc. to industry peers.
Does ERNA pay dividends?
Ernexa Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ERNA?
Analyst ratings and recommendations for ERNA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ERNA?
As of the Oct 16, 2026 close, Ernexa Therapeutics's market capitalization is $2.5M, classifying it as a micro-cap company. Ernexa Therapeutics operates in the Healthcare sector within the Biotechnology industry.